Competence Centre on Health Technologies established an international consortium to boost Personalised Medicine product development

Competence Centre on Health Technologies (CCHT) has been preparing a Personalised Medicine project since last year, in the framework of the Competence Centre programme supported via Enterprise Estonia. The project focuses on the development of applications using integrated genome- and other health data. The consortium members are Competence Centre on Health Technologies (Estonia), University of Tartu Estonian Genome Center (Estonia), Tallinn University of Technology e-Medicine Laboratory (Estonia), BioEximi OÜ (Estonia), Duodecim Medical Publications Ltd. (Finland), Medisapiens Ltd. (Findland) and Coimbra Genomics (Portugal).

The first collaboration project “Assessment of terms for the development of clinically valid and commercially viable personalised medicine products and services” will be accomplished by May 2016, resulting in a description of products and services which the consortium expects to bring to the market together. A business model will be selected and consequent subproject phases will be agreed. To enable direct application to clinical practice and prevention, clinical experts from Estonia and elsewhere will be invited to counsel the consortium.

The CEO of CCHT Prof. Andres Salumets explained that the CCHT will build on the rapid development and high potential Estonia has achieved in the combined use of health and genome data on national level. CCHT will consolidate remarkable research competence and international practice for Personalised Medicine decision support systems development and commercialisation. “Our consortium has the potential for smooth development and application in Estonia and elsewhere. CCHT could also be a partner for the Estonian government in preparing and implementing the Personalised Medicine Pilot Project”, he suggested.

The project is co-financed by the European Regional Development Fund via Enterprise Estonia, the CCHT and its consortium partners.

Tervisetehnoloogiate Arenduskeskus AS (CCHT; EE) is a research and technology organisation focused on applied research and product development in personalised medicine, drug development and reproductive medicine. University of Tartu Estonian Genome Center is an Estonian population-based biobank with a cohort size of over 50,000 people. Tallinn University of Technology e-Medicine Laboratory is focused on research and development in the field of e-medicine and health data. BioEximi OÜ is in the business of reproductive medicine, biotechnology and consulting. Duodecim Medical Publications Ltd. is a subsidiary of the Finnish doctors’ and Medial students scientific society engaged in the business of Clinical Decision Support applications development. Medisapiens Ltd. is a bioinformatics company providing software and architecture solutions to biotech, personalised medicine, pharma industry and research organisations. Coimbra Genomics is a biotechnology start- up developing clinical decision support systems based on genome data.

Additional Inoformation

Krista Kruuv-Käo, (krista.kruuv-kao [at] ccht.ee)